Doxorubicin Hydrochloride 50mg Injection

Doxorubicin Hydrochloride 50mg is conventional anthracycline chemotherapy used in breast cancer, lymphomas, leukaemias and selected other tumours. It is commonly combined with other medicines in cancer-specific treatment regimens.
The dose is administered into a vein through a freely flowing intravenous line. Blood counts, liver function and heart function are assessed around treatment cycles. This conventional preparation is not dosed as a liposomal product.
Doxorubicin inserts into DNA and inhibits topoisomerase II, producing DNA breaks and disrupting tumour-cell division.
Hair loss, nausea, mouth ulcers and low blood counts can occur. Cumulative heart-muscle damage and severe tissue injury after leakage are important risks.
Previous anthracyclines and chest radiotherapy contribute to cardiac risk. Tell the team about heart or liver disease and earlier chemotherapy. Avoid pregnancy during treatment.
Contributes to tumour shrinkage and disease control within established combination chemotherapy regimens.
The medicine’s pigment can discolour urine temporarily. Persistent redness, clots or urinary pain needs assessment.
No. Conventional and liposomal formulations differ in distribution, dose schedules and adverse effects.
Heart toxicity is related partly to the total amount received over time, including earlier treatment courses.
Report burning, pain or swelling at the intravenous site immediately so possible leakage can be assessed.
Anthracycline: a chemotherapy class that damages DNA. Topoisomerase II: an enzyme involved in DNA replication. Cumulative dose: the total amount received over successive treatments.; AR: Doxorubicin Hydrochloride 50mg حقن; FR: Doxorubicin Hydrochloride 50mg injection; PT: Doxorubicin Hydrochloride 50mg injeção; ES: Doxorubicin Hydrochloride 50mg inyección; RU: Doxorubicin Hydrochloride 50mg инъекция; ID: Doxorubicin Hydrochloride 50mg suntikan; VI: Doxorubicin Hydrochloride 50mg thuốc tiêm; MS: Doxorubicin Hydrochloride 50mg suntikan; TL: Doxorubicin Hydrochloride 50mg iniksyon; ZH-SG: Doxorubicin Hydrochloride 50mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Doxorubicin Hydrochloride 50mg Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Doxorubicin Hydrochloride 50mg Injection